Yellow fever

被引:18
作者
Litvoc, Marcelo Nobrega [1 ]
Gallafrio Novaes, Christina Terra [1 ]
Banks Ferreira Lopes, Max Igor [1 ]
机构
[1] Univ Sao Paulo FMUSP, Fac Med, Hosp Clin, Div Infect Dis, Sao Paulo, SP, Brazil
来源
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA | 2018年 / 64卷 / 02期
关键词
Yellow Fever; Epidemiology Brazil; Clinical Aspects; Treatment Perspectives; Vaccine;
D O I
10.1590/1806-9282.64.02.106
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The yellow fever (YF) virus is a Flavivirus, transmitted by Haemagogus, Sabethes or Aedes aegypti mosquitoes. The disease is endemic in forest areas in Africa and Latin America leading to epizootics in monkeys that constitute the reservoir of the disease. There are two forms of YF: sylvatic, transmitted accidentally when approaching the forests, and urban, which can be perpetuated by Aedes aegypti. In Brazil, the last case of urban YF occurred in 1942. Since then, there has been an expansion of transmission areas from the North and Midwest regions to the South and Southeast. In 2017, the country faced an important outbreak of the disease mainly in the states of Minas Gerais, Espirito Santo and Rio de Janeiro. In 2018, its reach extended from Minas Gerais toward Sao Paulo. Yellow fever has an incubation period of 3 to 6 days and sudden onset of symptoms with high fever, myalgia, headache, nausea/ vomiting and increased transaminases. The disease ranges from asymptomatic to severe forms. The most serious forms occur in around 15% of those infected, with high lethality rates. These forms lead to renal, hepatic and neurological impairment, and bleeding episodes. Treatment of mild and moderate forms is symptomatic, while severe and malignant forms depend on intensive care. Prevention is achieved by administering the vaccine, which is an effective (immunogenicity at 90-98%) and safe (0.4 severe events per 100,000 doses) measure. In 2018, the first transplants in the world due to YF were performed. There is also an attempt to evaluate the use of active drugs against the virus in order to reduce disease severity.
引用
收藏
页码:106 / 113
页数:8
相关论文
共 12 条
[1]  
[Anonymous], 2017, Wkly Epidemiol Rec, V92, P345
[2]  
[Anonymous], 2013, Wkly Epidemiol Rec, V88, P269
[3]  
Franco O., 1969, Historia da febre-amarela no brasil
[4]  
Freitas C, 2018, YELLOW FEVER VIRUS I, DOI [10.1101/266361., DOI 10.1101/266361]
[5]  
Ministerio da Saude (Brazil), 2018, FEBR AM GUIA PROSS S
[6]  
Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
[7]   Yellow fever [J].
Monath, Thomas P. ;
Vasconcelos, Pedro F. C. .
JOURNAL OF CLINICAL VIROLOGY, 2015, 64 :160-173
[8]   Yellow Fever - Once Again on the Radar Screen in the Americas [J].
Paules, Catharine I. ;
Fauci, Anthony S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (15) :1397-1399
[9]   Yellow fever: 100 years of discovery [J].
Staples, J. Erin ;
Monath, Thomas P. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (08) :960-962
[10]  
Staples JE, 2015, MMWR-MORBID MORTAL W, V64, P647